Health Care Select Sector... (XLV)
149.01
1.79 (1.22%)
At close: Feb 28, 2025, 3:59 PM
149.04
0.02%
Pre-market: Mar 03, 2025, 05:01 AM EST
No 1D chart data available
| Bid | 147.55 |
| Market Cap | 39.93B |
| AUM | 39.42B |
| NAV | 147.1 |
| EPS (ttm) | 4.62 |
| PE Ratio (ttm) | 32.28 |
| Shares Out | 267.97M |
| Inception Date | Dec 16, 1998 |
| Ask | 149.8 |
| Volume | 7M |
| Open | 147.45 |
| Previous Close | 147.22 |
| Day's Range | 146.49 - 149.01 |
| 52-Week Range | 135.95 - 159.64 |
| Holdings | 62 |
| Expense Ratio | 0.09% |
About XLV
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Asset Class Equity
Ticker Symbol XLV
Inception Date Dec 16, 1998
Provider State Street
Website Fund Home Page
Top 10 Holdings 57.60% of assets
| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly And Compan... | 13.36% | |
| Unitedhealth Group I... | 8.05% | |
| Johnson & Johnson | 7.32% | |
| Abbvie Inc. | 6.80% | |
| Abbott Laboratories | 4.41% | |
| Merck & Co., Inc. | 4.30% | |
| Intuitive Surgical, ... | 3.76% | |
| Thermo Fisher Scient... | 3.73% | |
| Amgen Inc. | 3.05% | |
| Boston Scientific Co... | 2.82% |
Dividends Dividend Yield 1.65%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 23, 2024 | $0.6217 | Dec 26, 2024 |
| Sep 23, 2024 | $0.5772 | Sep 25, 2024 |
| Jun 24, 2024 | $0.5725 | Jun 26, 2024 |
| Mar 18, 2024 | $0.5229 | Mar 21, 2024 |
| Dec 18, 2023 | $0.5977 | Dec 21, 2023 |
1 week ago
-0.54%
Shares of health insurers are trading lower. Weakn...
Unlock content with
Pro Subscription
1 week ago · seekingalpha.com
THW: NAV Growth Starting To ImproveTHW: NAV Growth Starting To Improve
